New flu pill for kids shows promise in early trial

NCT ID NCT07229807

Ongoing Symptom relief Sponsor: Guangdong Raynovent Biotech Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new medicine called ZSP1273 in children aged 2 to 11 who have influenza A. The goal is to see if it can shorten flu symptoms and is safe. About 119 children in China will take either ZSP1273 or the standard flu drug oseltamivir.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ZSP1273 granules
What this could lead to: If it works, this could provide a new treatment option to help children recover faster from influenza A.
What could go wrong: This is a mid-stage trial with only 119 participants in China, so results may not apply broadly. The drug may not prove more effective than existing treatments like oseltamivir.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

swine influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLUENZA A

Contacts and locations

Locations

Beijing Children Hospital

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.